Newtech, Inc., a Leading Chinese EMS Patient Monitoring Company, Partners with Masimo to Incorporate rainbow® SET Noninvasive Measurement Capabilities into New Patient Monitors.

Newtech, Inc., and Masimo Corporation (NASDAQ: MASI) jointly announced today a new technology integration strategy that will make the Masimo rainbow SET Pulse CO-Oximetry™ technology platform a fundamental offering in Newtech’s emergency medical services (EMS) and multiparameter product line-up—providing clinicians with a host of innovative new noninvasive, continuous measurements and patient monitoring capabilities for the immediate detection of potentially life-threatening conditions.

“By incorporating the Masimo rainbow SET technology into our products, we will be able to offer the EMS market in China the most advanced technologies in monitoring EMS patients,” said Ganbing Wang, President of Newtech, Inc. “We see huge potential within China’s EMS market over the next five years because of strong government investment to upgrade the EMS system and, being an innovative medical device company, we are pleased to partner with Masimo in providing the best technology for our customers to meet not only their current demands, but their future demands as well.”

Masimo rainbow SET noninvasive and continuous measurements—like total hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), Pleth Variability Index (PVI®), and rainbow Acoustic Monitoring™ (RAM™), in addition to the “gold-standard” Measure-Through Motion and Low Perfusion performance of Masimo SET® oxyhemoglobin (SpO2), perfusion index (PI), and pulse rate (PR)—provide detailed physiological data that helps clinicians to more rapidly assess patients and detect adverse conditions earlier. Immediate availability of such detailed clinical intelligence and measurement data enables clinicians to proactively detect and treat the early signs of hemodynamic instability, potentially life-threatening conditions and internal bleeding sooner rather than reacting to late indicators and their deleterious effects.

Newtech’s utilization of broadband wireless technologies allows seamless transmission of patient-critical vital sign information over China’s Emergency Medical 3G and 4G networks and the internet. This real-time, live streaming of video, audio and vital signs data provides caregivers with the ability to immediately assess and treat their patients, at the point of care or during ambulance transport. Information is transmitted by the multiparameter handheld (NT1D) or NT3C and NT5 ambulance mounted patient monitors, to a base station, which may be either a remote centralized monitoring system or hospital Emergency Department, where caregivers are alerted in advance and may prepare treatment regimens.

Pre-hospital/EMS early interventions have been shown to dramatically reduce “call to needle” or “door to needle” treatment times, especially in rural areas, resulting in lower mortality rates, improved patient outcomes and survival rates. Incorporating Masimo rainbow SET technology expands the clinician’s ability to assess and treat the pre-hospital/EMS patient to now include noninvasive monitoring of critical blood constituents such as hemoglobin (SpHb), Pleth Variability Index (PVI), and carboxyhemoglobin (SpCO), so that a caregiver may evaluate and treat for blood loss, anemia, and even suspected carbon monoxide poisoning before the patient has reached the hospital.

Masimo President of Worldwide OEM Business & Business Development, Rick Fishel, stated, “Masimo’s mission is to improve patient outcomes and reduce the cost of care by taking noninvasive monitoring to new sites and applications. Newtech’s innovative approach to real-time monitoring of patients—in remote/rural settings, during ambulance transport, at the point of care, or wherever the care setting may be—represents a shared vision to bring technology to the patient rather than the patient to the technology, so that care may begin as early as possible. We are very pleased that Masimo’s unique rainbow Pulse CO-Oximetry platform is a key component in Newtech’s new patient monitors.”

Comments are closed.

Copyright Promed Technologies 2017